You are here

Albert Labs International Corp.

Albert Labs International Corp.
Listing Exchange: 
CSE
Status: 
Active
Industry: 
Life Sciences
Symbol: 
ABRT
CSE Index: 
Currency: 

Albert Labs International Corp. is a research and drug development company addressing mental health care needs. Through a succinct clinical pathway, focusing on Real World Evidence (RWE) Albert Labs look to commercialize its psychedelic-based treatments, and in doing so deliver psychedelic-assisted psychotherapy to patients sooner. Focused on accelerating access and faster approvals, Albert Labs put patients with urgent and unmet needs first as it develops licensed medicines to treat a variety of mental health conditions. Cancer-related distress, an initial focus of Albert Labs development program is thought to affect over 16 million patients worldwide.

You are here

Albert Labs International Corp. (ABRT)

SEDAR Information

Company Info

Address
#201 - 6996 Merritt Avenue
Burnaby, BC V5J 4R6
Canada
Phone
(778) 819 0740
Email
info@albertlabs.com
Website
https://www.albertlabs.com
Listing date
Tuesday, September 6, 2011
Transfer Agent
Computershare Investor Services Inc.

Advertisement

Publicité

Capitalization

Issued & Outstanding: 
67,280,035
Reserved for Issuance: 
0

Bulletins

09/03/2022

2022-0312 - Fundamental Change - ME Resource Corp./Albert Labs International Corp.

le 9 mars/March 2022

The common shares of Albert Labs International Corp., previously listed as ME Resource Corp., (MEC) have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.

Advertisement

Publicité

Latest CSE News

Upcoming Events